Pharmaceutical Product Registration in Nigeria - Overview
The National Agency for Food and Drug Administration and Control (NAFDAC) is the key drug Regulatory Authority for regulating and Pharmaceutical Product Registration in Nigeria. The Agency was established by Decree No. 15 of 1993, as amended by Decree No. 19 of 1999. Now, the National Agency for Food and Drug Administration and Control Act Cap N1 Laws of the Federation of Nigeria (LFN), 2004, is responsible for regulating and controlling the manufacture, importation, exportation, distribution, advertisement, sale, and use of drugs.
Medicinal Product Classification in Nigeria
Medicines are broadly subdivided into the following categories for the submission of pharmaceutical product registration in Nigeria:
- Prescription-only Medicines.
- Over-the-Counter (OTC) Medicines.
Medicinal Product Registration in Nigeria
The process of submitting a new Marketing Authorization Application (MAA) consists of the following phases:
A) Six-Step Market Authorization Procedure
Step 1: Trademark Registration and Approval
It is mandatory to get a trademark registration done before pharmaceutical product registration in Nigeria. The Ministry of Industry Trade and Investment’s Commercial Law Department Trademarks, Patents, and Designs Registry is responsible for registering trademarks in Nigeria.
Step 2: Dossier Submission & Screening Process
The application must be submitted along with all the documentation to the NAFDAC for screening.
Step 3: Import Permit and Label Vetting
An import permit is issued upon successful screening of documentation and review of supporting documents. Post this, the products are submitted for vetting.
Step 4: Submission of Samples for Laboratory Analysis
Laboratory samples are submitted after the successful vetting of product labels.
Step 5: Product Approval Meeting
The products are presented for ‘Approval Meetings’ after the satisfactory review of the dossier, GMP of the production facility, and laboratory analysis.
Step 6: Issuance of Notification
For products approved at the Annual Meeting, notification of registration or listing will be issued to the applicant, and a compliance directive will be issued for Nigeria drug registration and approval products.
B) Collaborative Registration Procedure
It is an accelerated Nigeria drug registration and approval procedure for pharmaceutical product registration in Nigeria under the World Health Organization Prequalification of Medicines Program (PQP), the West African Health Organization’s joint drug product assessment procedure, and Stringent Regulatory Agencies (SRAs, facilitated by the World Health Organization) through improved information sharing.
C) Importance of a Local Entity for a Foreign Manufacturer
The NAFDAC drug registration guidelines mandate the appointment of a local agent/legal representative in Nigeria for foreign manufacturers. The local agent/legal representative is responsible for all communications between the manufacturer and the NAFDAC.
Product Maintenance & Compliance
Validity of Registration Certificate
Post Approval Changes (Variations)
The certificate of registration is valid for five (05) years.
The renewal application should be submitted thirty (30) days before the expiration of the existing registration certificate.
Information on any changes in registered medicine should be sent to the NAFDAC with relevant documents.
Pharmaceutical Product Registration in Nigeria - Freyr Expertise
- Trademark Registration Process.
- End-to-end Pharmaceutical Product Registration in Nigeria.
- Authorized Local Agent Support.
- Nigeria Drug Registration and Approval.
- Manufacturing Site Approval Support.
- Import License Support.
- Regulatory Affairs Consulting.
- Pharmaceutical Dossier Preparation and Submission for the NAFDAC Registration.
- Preparation of Gap Analysis Report and Remediation Plan.
- Compilation and Submission of the Dossier to the NAFDAC.
- Faster Pharma Market Access.
- NAFDAC Product Registration.
- Query Support Management till Approval.
- Pharmaceutical Lifecycle Management Support.
- Ad-hoc Regulatory Affairs Consultation.